Treating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians never know when, where and what resistance might emerge, leaving them one step behind. But a team led by Penn State researchers has found a way to reprogram disease evolution and design tumors that are easier to treat.
They created a modular genetic circuit that turns cancer cells into a “Trojan horse,” causing them to self-destruct and kill nearby drug-resistant cancer cells. Tested in human cell lines and in mice as proof of concept, the circuit outsmarted a wide range of resistance.
The findings were published today, July 4, in the journal Nature Biotechnology. The researchers also filed a provisional application to patent the technology described in the paper.
In this thought-provoking lecture, Prof. Jay Friedenberg from Manhattan College delves into the intricate interplay between cognitive science, artificial intelligence, and ethics. With nearly 30 years of teaching experience, Prof. Friedenberg discusses how visual perception research informs AI design, the implications of brain-machine interfaces, the role of creativity in both humans and AI, and the necessity for ethical considerations as technology evolves. He emphasizes the importance of human agency in shaping our technological future and explores the concept of universal values that could guide the development of AGI for the betterment of society.
00:00 Introduction to Jay Friedenberg. 01:02 Connecting Cognitive Science and AI 02:36 Human Augmentation and Technology. 03:50 Brain-Machine Interfaces. 05:43 Balancing Optimism and Caution in AI 07:52 Free Will vs Determinism. 12:34 Creativity in Humans and Machines. 16:45 Ethics and Value Alignment in AI 20:09 Conclusion and Future Work.
SingularityNET was founded by Dr. Ben Goertzel with the mission of creating a decentralized, democratic, inclusive, and beneficial Artificial General Intelligence (AGI). An AGI is not dependent on any central entity, is open to anyone, and is not restricted to the narrow goals of a single corporation or even a single country.
The SingularityNET team includes seasoned engineers, scientists, researchers, entrepreneurs, and marketers. Our core platform and AI teams are further complemented by specialized teams devoted to application areas such as finance, robotics, biomedical AI, media, arts, and entertainment.
In this study we show that residual muscle–tendon afferents enable a person with transtibial amputation to directly neuromodulate biomimetic locomotion, enabling neuroprosthetic adaptations to varying walking speeds, terrains and perturbations. Such versatile and biomimetic gait has not been attainable in contemporary bionic legs without the reliance upon predefined intrinsic control frameworks1,2. Central to the improved neural controllability demonstrated in this study are muscle–tendon sensory organs26,27 that deliver proprioceptive afferents. The surgically reconstructed, agonist–antagonist muscles emulate natural agonistic contraction and antagonistic stretch, thereby generating proprioceptive afferents corresponding to residual muscle movements.
During the ground contact phase of walking, the reconstructed muscle–tendon dynamics of the AMI do not precisely emulate intact biological muscle dynamics. The residual muscles of the AMI contract and stretch freely within the amputated residuum, only pulling against one another and not against the external environment. In distinction, for intact biological limbs, the muscle–tendons span the ankle joint, exerting large forces through an interaction with the external environment. These interactive muscle–tendon dynamics in intact biological limbs are believed to play a critical role in spinal reflexes, in addition to providing feedback for volitional motor control12. Therefore, for this study, the demonstrated capacity of augmented afferents to enable biomimetic gait neuromodulation is surprising given that their total magnitude is largely reduced compared with those of intact biological limbs26,27,45,46.
Neurological disorders, such as trauma, stroke, epilepsy, and various neurodegenerative diseases, often lead to the permanent loss of neurons, causing significant impairments in brain function. Current treatment options are limited, primarily due to the challenge of replacing lost neurons.
Direct neuronal reprogramming, a complex procedure that involves changing the function of one type of cell into another, offers a promising strategy.
In cell culture and in living organisms, glial cells—the non-neuronal cells in the central nervous system—have been successfully transformed into functional neurons. However, the processes involved in this reprogramming are complex and require further understanding. This complexity presents a challenge, but also a motivation, for researchers in the field of neuroscience and regenerative medicine.
Arc Institute scientists have discovered the bridge recombinase mechanism, a revolutionary tool that enables fully programmable DNA rearrangements.
Their finding, detailed in a recent Nature publication, is the first DNA recombinase that uses a non-coding RNA for sequence-specific selection of target and donor DNA molecules. This bridge RNA is programmable, allowing the user to specify any desired genomic target sequence and any donor DNA molecule to be inserted.
The research was developed in collaboration with the labs of Silvana Konermann, Arc Institute Core Investigator and Stanford University Assistant Professor of Biochemistry, and Hiroshi Nishimasu, Professor of Structural Biology at the University of Tokyo.
The results of this study link volume loss of hippocampal output structures, and in particular the subiculum, to functional cognitive impairment and to amyloid and tau copathologies in Lewy body diseases:
A new microscopy method has allowed researchers to detect tiny changes in the atomic-level architecture of crystalline materials like advanced steels for ship hulls and custom silicon for electronics. It could advance our ability to understand the fundamental origins of materials properties and behaviour.
In a paper published today in Nature Materials, researchers from the University of Sydney’s School of Aerospace, Mechanical and Mechatronic Engineering introduced a new way to decode the atomic relationships within materials.
The breakthrough could assist in the development of stronger and lighter alloys for the aerospace industry, new generation semiconductors for electronics, and improved magnets for electric motors. It could also enable the creation of sustainable, efficient and cost-effective products.
Researchers at Rice University are making strides in understanding how chromosome structures change throughout the cell’s life cycle. Their study on motorized processes that actively influence the organization of chromosomes appears in the Proceedings of the National Academy of Science.
“This research provides a deeper understanding of how motorized processes shape chromosome structures and influence cellular functions,” said Peter Wolynes, study co-author and the D.R. Bullard-Welch Foundation Professor of Science. Wolynes is also a professor of chemistry, biosciences, physics and astronomy and the co-director of the Center for Theoretical Biological Physics (CTBP).
The research introduces two types of motorized chain models: swimming motors and grappling motors. These motors play distinct roles in manipulating chromosome structure.
